Monday, December 20, 2021 1:59:50 PM
In the early winter of 21, NVAX was trading in the $3 range, as we are. They have an enviable share structure, but our OS is even lower. They were the front-runner vaccine, as we are the front-runner therapeutic.
By May of 21, NVAX was trading at $46. Just over a year from when they were trading in the $3 range, they reached what remains their all-time high of over $300.
As dangerous as Covid was to the world last year, without vaccines, I think it is even more dangerous now, with ineffective vaccines. And only our patent-protected lenz will prevent disease progression of hospitalized and hypoxic patients.
I was hoping for some news this morning from Durrant regarding Kessler procuring all the lenz we could supply to the White House Covid task force.
I remain optimistic...but extremely anxious, as well. Come on, Cameron, stick the landing. And if they don't want to pay what we will be getting from Europe, I don't think they should, anyway. They need to pay more for causing the dilution of our share value.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM